Beijing suspends Ali Health-run online drug monitoring platform
Authorities drafting amendments to rules monitoring pharmaceutical sales
Add BT as a preferred sourceDeeperDive is a beta AI feature. Refer to full articles for the facts.
Beijing
CHINA'S food and drugs regulatory body said it had suspended its electronic drug monitoring system, a platform operated by Alibaba Health Information Technology Ltd, while it drafts amendments to regulations monitoring pharmaceutical sales.
The China Food and Drug Administration (CFDA) said that it will seek comments until March 23 on changes to the way pharmaceutical products are monitored, including online sales, according to statements posted on its website on Saturday.
Share with us your feedback on BT's products and services
TRENDING NOW
Air India asks Tata, Singapore Airlines for funds after US$2.4 billion loss
‘Boring’ is the new black: The stars are aligning for a Singapore stock market revival
From 1MDB to ‘corporate mafia’: Is Malaysia facing a new governance test?
South-east Asian markets account for 8.8% of global capital inflows from 2021 to 2024: report
